![Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/db5c63dc-ee49-4b78-b05c-e93ffa8229af/gr1_lrg.jpg)
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet
![Inhibition of Complement Factor 3 in Geographic Atrophy with NGM621: Phase 1 Dose-Escalation Study Results - American Journal of Ophthalmology Inhibition of Complement Factor 3 in Geographic Atrophy with NGM621: Phase 1 Dose-Escalation Study Results - American Journal of Ophthalmology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/522c7a0e-d512-48c0-a799-c432483d9f1b/gr1_lrg.jpg)
Inhibition of Complement Factor 3 in Geographic Atrophy with NGM621: Phase 1 Dose-Escalation Study Results - American Journal of Ophthalmology
Should FDA Reconsider Allowing the Pooling of COVID-19 Vaccine Doses to Obtain Additional Doses? | Institute For Safe Medication Practices
![Walgreens Tioconazole Ointment 6.5 Percent, 1-Dose Treatment for Vaginal Yeast Infection | Walgreens Walgreens Tioconazole Ointment 6.5 Percent, 1-Dose Treatment for Vaginal Yeast Infection | Walgreens](https://pics.drugstore.com/prodimg/369899/900.jpg)
Walgreens Tioconazole Ointment 6.5 Percent, 1-Dose Treatment for Vaginal Yeast Infection | Walgreens
![A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot Trial | American Society of Nephrology A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot Trial | American Society of Nephrology](https://jasn.asnjournals.org/content/jnephrol/31/1/161/F1.large.jpg)
A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot Trial | American Society of Nephrology
![Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England | Nature Communications Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-021-27410-5/MediaObjects/41467_2021_27410_Fig1_HTML.png)
Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England | Nature Communications
![Effectiveness of a fourth dose of mRNA COVID-19 vaccine against all-cause mortality in long-term care facility residents and in the oldest old: A nationwide, retrospective cohort study in Sweden - The Lancet Effectiveness of a fourth dose of mRNA COVID-19 vaccine against all-cause mortality in long-term care facility residents and in the oldest old: A nationwide, retrospective cohort study in Sweden - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/0b6e43e1-5d59-4d2b-aeeb-50247c037446/gr1.jpg)
Effectiveness of a fourth dose of mRNA COVID-19 vaccine against all-cause mortality in long-term care facility residents and in the oldest old: A nationwide, retrospective cohort study in Sweden - The Lancet
![Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ](https://www.bmj.com/content/bmj/373/bmj.n1087/F1.large.jpg)
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ
![Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021 | MMWR Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7018e1_EffectivenessOlderAdults_IMAGE_28Apr21_1200x675.jpg)
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021 | MMWR
![Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: A retrospective cohort study - The Lancet Regional Health – Americas Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: A retrospective cohort study - The Lancet Regional Health – Americas](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/5557f81b-f2fa-4495-b28e-6444a92cb07a/gr1.jpg)
Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: A retrospective cohort study - The Lancet Regional Health – Americas
![Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity - ScienceDirect Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0092867421002981-fx1.jpg)
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity - ScienceDirect
![Are Health Centers Facilitating Equitable Access to COVID-19 Vaccinations? A June 2021 Update. | KFF Are Health Centers Facilitating Equitable Access to COVID-19 Vaccinations? A June 2021 Update. | KFF](https://www.kff.org/wp-content/uploads/2021/06/the-majority-of-people-who-received-the-covid-19-vaccine-from-health-centers-were-people-of-color-.png)